Polytherics was founded in 2002 as a spinoff from the Imperial College, London and London School of Pharmacy. It has to date raised around £7.5million of funds, has around 30 employees based in Central London and has patents granted in US, Europe, India and China.

Polytherics is no stranger to India and has been working with Indian partners since 2005, when it created a partnership with Shantha Biotechnics (now a part of Sanofi) to create an affordable PEG-Interferon for Hepatitis C.

Related Case Studies

Get a free consultation with one of our India Advisers

All personal data herein are processed in accordance with UK data protection legislation. All feasible security measures are in place. You may withdraw consent at any time in the future.